Compile Data Set for Download or QSAR
Report error Found 59 Enz. Inhib. hit(s) with all data for entry = 11207
TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600562BDBM600562((S)-2,2,2-Trifluoro-1-(5-(pyridin-4-ylmethyl)-1H-i...)
Affinity DataIC50: 1.00E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600561BDBM600561((S)-2,2,2-Trifluoro-1-(5-(pyridin-4-ylmethyl)-1H-i...)
Affinity DataIC50: 1.00E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600560BDBM600560(US11629136, Example 6)
Affinity DataIC50: 1.00E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600591BDBM600591(US11629136, Example 27)
Affinity DataIC50: 1.00E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600598BDBM600598((R)-1,1,1-Trifluoro-2-(5-(pyridin-4-ylmethyl)-1H-i...)
Affinity DataIC50: 1.00E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600567BDBM600567(US11629136, Example 12)
Affinity DataIC50: 1.00E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600605BDBM600605(US11629136, Example 36)
Affinity DataIC50: 1.00E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600571BDBM600571((S)-2,2,2-Trifluoro-1-(4-(pyridin-4-ylmethyl)-1H-i...)
Affinity DataIC50: 1.00E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600608BDBM600608((S)-2,2,2-Trifluoro-1-(4-((3-fluoropyridin-4-yl)me...)
Affinity DataIC50: 1.00E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600607BDBM600607((S)-2,2,2-Trifluoro-1-(4-((3-methylpyridin-4-yl)me...)
Affinity DataIC50: 1.00E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600580BDBM600580((S)-(4-(Pyridin-4-ylmethyl)-1H-imidazol-2-yl)(thia...)
Affinity DataIC50: 1.00E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600586BDBM600586(US11629136, Example 24b)
Affinity DataIC50: 1.00E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600553BDBM600553(US11629136, Example 1)
Affinity DataIC50: 1.00E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600584BDBM600584(US11629136, Example 24)
Affinity DataIC50: 1.00E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600583BDBM600583(US11629136, Example 23)
Affinity DataIC50: 1.00E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600558BDBM600558(US11629136, Example 5a)
Affinity DataIC50: 1.00E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600590BDBM600590((R)-2,2,2-Trifluoro-1-(4-(pyridin-4-ylmethyl)-1H-i...)
Affinity DataIC50: 1.00E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600557BDBM600557(US11629136, Example 5)
Affinity DataIC50: 1.00E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600588BDBM600588(US11629136, Example 25)
Affinity DataIC50: 1.00E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600555BDBM600555(US11629136, Example 3)
Affinity DataIC50: 1.00E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600559BDBM600559(US11629136, Example 5b)
Affinity DataIC50: 5.50E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600566BDBM600566(US11629136, Example 11)
Affinity DataIC50: 5.50E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600565BDBM600565(US11629136, Example 10)
Affinity DataIC50: 5.50E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600597BDBM600597((R)-(5-(pyridin-4-ylmethyl)-1H-imidazol-2-yl)(thia...)
Affinity DataIC50: 5.50E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600564BDBM600564(US11629136, Example 9)
Affinity DataIC50: 5.50E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600594BDBM600594(US11629136, Example 30a | (S)-(5-((3-Methylpyridin...)
Affinity DataIC50: 5.50E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600570BDBM600570((S)-2,2,2-Trifluoro-1-(4-(pyridin-4-ylmethyl)-1H-i...)
Affinity DataIC50: 5.50E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600600BDBM600600(US11629136, Example 33a | (S)-4-((2-(2,2,2-trifluo...)
Affinity DataIC50: 5.50E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600568BDBM600568(US11629136, Example 13)
Affinity DataIC50: 5.50E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600600BDBM600600(US11629136, Example 33a | (S)-4-((2-(2,2,2-trifluo...)
Affinity DataIC50: 5.50E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600599BDBM600599((R)-1,1,1-Trifluoro-2-(5-(pyridin-4-ylmethyl)-1H-i...)
Affinity DataIC50: 5.50E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600606BDBM600606((S)-2,2,2-Trifluoro-1-(4-((3-methylpyridin-4-yl)me...)
Affinity DataIC50: 5.50E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600573BDBM600573((S)-2,2,2-Trifluoro-N-methyl-1-(5-(pyridin-4-ylmet...)
Affinity DataIC50: 5.50E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600572BDBM600572((S)-2,2,2-Trifluoro-N-methyl-1-(5-(pyridin-4-ylmet...)
Affinity DataIC50: 5.50E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600604BDBM600604(US11629136, Example 35)
Affinity DataIC50: 5.50E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600578BDBM600578((S)-2,2,2-Trifluoro-1-(5-(pyridin-4-ylmethyl)thiaz...)
Affinity DataIC50: 5.50E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600610BDBM600610(US11629136, Example 39)
Affinity DataIC50: 5.50E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600609BDBM600609((S)-2,2,2-Trifluoro-1-(4-((3-fluoropyridin-4-yl)me...)
Affinity DataIC50: 5.50E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600575BDBM600575((S)-2,2,2-Trifluoro-N,N-dimethyl-1-(5-(pyridin-4-y...)
Affinity DataIC50: 5.50E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600579BDBM600579((S)-(4-(Pyridin-4-ylmethyl)-1H-imidazol-2-yl)(thia...)
Affinity DataIC50: 5.50E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600611BDBM600611(US11629136, Example 40)
Affinity DataIC50: 5.50E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600554BDBM600554(US11629136, Example 2)
Affinity DataIC50: 5.50E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600556BDBM600556(US11629136, Example 4)
Affinity DataIC50: 5.50E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600594BDBM600594(US11629136, Example 30a | (S)-(5-((3-Methylpyridin...)
Affinity DataIC50: 5.50E+4nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600577BDBM600577((S)-2,2,2-Trifluoro-1-(5-(pyridin-4-ylmethyl)thiaz...)
Affinity DataIC50: 5.50E+4nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600582BDBM600582(US11629136, Example 22)
Affinity DataIC50: 5.50E+4nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600581BDBM600581(US11629136, Example 21)
Affinity DataIC50: 5.50E+4nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600563BDBM600563(US11629136, Example 8)
Affinity DataIC50: 5.50E+4nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600569BDBM600569(US11629136, Example 14)
Affinity DataIC50: 5.50E+4nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

TargetNAD(+) hydrolase SARM1 [50-724](Human)
Nura Bio

US Patent
LigandChemical structure of BindingDB Monomer ID 600585BDBM600585(US11629136, Example 24a)
Affinity DataIC50: 5.50E+4nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/27/2023
Entry Details
US Patent

Displayed 1 to 50 (of 59 total ) | Next | Last >>
Jump to: